Topic: "New therapeutic opportunities for the treatment of Parkinson's disease: focus on adenosine A2A receptor antagonists"
- Prof. Micaela Morelli (Cagliari, Italy)
Topic: Computer assisted Drug Design (CADD) and Bioinformatics, Tools for designing drugs and understanding their activity
- Dr Mahmoud E. Soliman (United Kingdom/Egypt)
Topic: "Safety and effectiveness of 1 % tenofovir gel in preventing HIV infection: results of the CAPRISA 004 trial and next steps"
- Dr Leila Mansoor (CAPRISA, Durban, South Africa)
Topic: Computer assisted Drug Design (CADD) and Bioinformatics, Tools for designing drugs and understanding their activity.
Speaker: Mahmoud E. Soliman, Department of Chemistry, University of Bath
Topic: Safety and effectiveness of 1 % tenofovir gel in preventing HIV infection: results of the CAPRISA 004 trial and next steps
- Speaker: Dr Leila Mansoor, CAPRISA 008 Co-Principal Investigator, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal
Speaker: Dr. Barry Richmond, Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland
|